Page 163 - CW E-Magazine (19-8-2025)

News from Abroad

ZEQL quicklime. The project has industries such as steel, construction, forms the foundation of the ZEQL
received Euro 24-mn in funding from pulp and paper, water treatment, and project. Following the signing of a
the Norwegian state enterprise Enova. agriculture. By investing in the ZEQL Letter of Intent in February 2025, both
pilot plant, SMA Mineral positions companies are working closely to-
SMA Mineral, one of the largest itself as a pioneer in the transition to gether to scale up electrifi ed industrial
lime producers in the Nordic region, sustainable lime production without the processes. This collaboration refl ects a
operates across Sweden, Norway, Fin- use of fossil fuels. shared commitment to innovation and
land, and Estonia. With over 90 years sustainability and marks a major step
of experience, the company supplies The partnership between SaltX forward in decarbonizing the cement
high-quality lime products to key Technology and Thyssenkrupp Polysius and lime industries.
ALLIANCE
Sartorius announces partnership to advance biopharma

manufacturing in Africa

Bio Usawa Biotechnology Ltd.,
an African biotechnology fi rm, and
Sartorius Stedim Biotech, a German
biopharma solutions provider, have
announced a partnership to accelerate
Africa’s biopharmaceutical industry
and address the continent’s urgent,
dual health burdens in infectious and
non-communicable diseases. This colla-
boration will focus on developing and
manufacturing aff ordable monoclonal
antibodies in Sub-Saharan Africa to
tackle oncology, diabetes-induced eye
diseases, infectious diseases, and auto-
immune conditions. The agreement
will also cover joint initiatives in work-
force development, process innovation, The partnership includes the following tech will provide its expertise in pro-
and technology transfer. core pillars: cess optimisation, ensuring robust,
 Research & Development: Sartorius scalable, cost-eff ective and compliant
“Africa is at a critical juncture in its Stedim Biotech will collaborate with manufacturing processes.
health trajectory. We are battling a twin Bio Usawa to develop biosimilar cell  Analytical and QC support: Sartorius
epidemic of infectious diseases and a lines tailored to therapeutic needs in Stedim Biotech’s capabilities in ana-
rapidly rising burden of non-communi- Africa. lytical characterisation and quality
cable diseases such as cancer and dia-  Workforce capacity building: The control testing will strengthen Bio
betes. Yet, lifesaving innovations often do companies will jointly design and Usawa’s product quality assurance
not reach the continent due to high costs deliver training programs for the African framework.
and late availability,” said Dr. Menghis biopharma workforce, nurturing local
Bairu, CEO of Bio Usawa. “Our part- talent for long-term sustainability. “Through this collaboration, we aim
nership with Sartorius Stedim Biotech is  Technology enablement: Sartorius not only to support technical innova-
transformational – it allows us to bring Stedim Biotech will supply biopro- tion but also to empower local talent and
advanced biomanufacturing technology cessing equipment, media, buff ers, infrastructure development to ensure
to Africa, train a new generation of and consumables for both upstream long-term, self-sustaining impact,” noted
African scientists, and produce innovative and downstream (drug substance and Ms. Michaela Pischke, Head of Business
biopharmaceuticals that are accessible fi ll-fi nish) manufacturing. Area Separation Technologies at Sartorius
and aff ordable for our people.”  Optimisation: Sartorius Stedim Bio- Stedim Biotech.

Chemical Weekly August 19, 2025 163

Contents Index to Advertisers Index to Products Advertised